RaQualia Pharma Inc. (4579.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 23.93B |
| Enterprise Value | 23.59B |
| P/E Ratio | 165.88 |
| PEG Ratio | -2.44 |
| Price/Sales Ratio | 3.15 |
| Price/Book Ratio | 1.55 |
| Enterprise/Revenue | 2.71 |
| Enterprise/EBITDA | 14.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 3.98B |
| Revenue/Share | 149.48 |
| Gross Profit | 3.27B |
| EBITDA | 985.17M |
| Net Income | 273.12M |
| Diluted EPS | 11.36 |
Balance Sheet
| Total Cash | 4.49B |
| Total Cash/Share | 176.03 |
| Total Debt | 2.79B |
| Total Debt/Equity | 0.34 |
| Current Ratio | 6.16 |
| Book Value Per Share | 316.72 |
Price History
| 52-Week Change | -8.05 |
| 52-Week High | 1,465 |
| 52-Week Low | 440 |
| Moving Average 50 Days | 555.52 |
| Moving Average 200 Days | 782.38 |
Statistics
| Average Volume | 219,609 |
| Shares Outstanding | 24.46M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
